Login / Signup

Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan).

Kenichi ShikataMasakazu HanedaToshiharu NinomiyaDaisuke KoyaYoshiki SuzukiDaisuke SuzukiHitoshi IshidaHiroaki AkaiYasuhiko TominoTakashi UzuMotonobu NishimuraShiro MaedaDaisuke OgawaSatoshi MiyamotoHirofumi Makinonull null
Published in: Journal of diabetes investigation (2020)
The risk of kidney events tended to decrease by IT, although it was not statistically significant. Lipid control using statin was associated with a lower risk of adverse kidney events. Further follow-up study might show the effect of IT in patients with advanced diabetic kidney disease.
Keyphrases
  • clinical trial
  • diabetic nephropathy
  • phase iii
  • type diabetes
  • study protocol
  • wound healing
  • randomized controlled trial
  • cardiovascular disease
  • palliative care
  • coronary artery disease
  • fatty acid
  • rheumatoid arthritis